ロード中...
5PSQ-003 Effectiveness and safety of vedolizumab in ulcerative colitis and crohn’s disease
BACKGROUND: Vedolizumab is a monoclonal antibody for the treatment of ulcerative colitis and Crohn’s disease. PURPOSE: The aim of this study was to determine the effectiveness and safety of vedolizumab in our hospital since its inclusion in the pharmaceutical guide in April 2016 to the current date...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535328/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.357 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|